ORGAN BLOOD FLOW DURING ARTERIOVENOUS CARBON DIOXIDE REMOVAL (AVCO2R)

ASAIO Journal ◽  
1997 ◽  
Vol 43 (2) ◽  
pp. 33 ◽  
Author(s):  
R. L. Brunston ◽  
W. Tao ◽  
A. Bidani ◽  
D. L. Traber ◽  
J. B. Zwischenberger
ASAIO Journal ◽  
1997 ◽  
Vol 43 (5) ◽  
pp. M825 ◽  
Author(s):  
ROBERT L. BRUNSTON ◽  
WEIKE TAO

ASAIO Journal ◽  
1996 ◽  
Vol 42 (5) ◽  
pp. M845-849 ◽  
Author(s):  
ROBERT L. BRUNSTON ◽  
WEIKE TAO ◽  
AKHIL BIDANI ◽  
VICTOR J. CARDENAS ◽  
DANIEL L. TRABER ◽  
...  

2014 ◽  
Vol 120 (2) ◽  
pp. 416-424 ◽  
Author(s):  
Alberto Zanella ◽  
Paolo Mangili ◽  
Sara Redaelli ◽  
Vittorio Scaravilli ◽  
Marco Giani ◽  
...  

Abstract Background: Extracorporeal carbon dioxide removal has been proposed to achieve protective ventilation in patients at risk for ventilator-induced lung injury. In an acute study, the authors previously described an extracorporeal carbon dioxide removal technique enhanced by regional extracorporeal blood acidification. The current study evaluates efficacy and feasibility of such technology applied for 48 h. Methods: Ten pigs were connected to a low-flow veno-venous extracorporeal circuit (blood flow rate, 0.25 l/min) including a membrane lung. Blood acidification was achieved in eight pigs by continuous infusion of 2.5 mEq/min of lactic acid at the membrane lung inlet. The acid infusion was interrupted for 1 h at the 24 and 48 h. Two control pigs did not receive acidification. At baseline and every 8 h thereafter, the authors measured blood lactate, gases, chemistry, and the amount of carbon dioxide removed by the membrane lung (VCO2ML). The authors also measured erythrocyte metabolites and selected cytokines. Histological and metalloproteinases analyses were performed on selected organs. Results: Blood acidification consistently increased VCO2ML by 62 to 78%, from 79 ± 13 to 128 ± 22 ml/min at baseline, from 60 ± 8 to 101 ± 16 ml/min at 24 h, and from 54 ± 6 to 96 ± 16 ml/min at 48 h. During regional acidification, arterial pH decreased slightly (average reduction, 0.04), whereas arterial lactate remained lower than 4 mEq/l. No sign of organ and erythrocyte damage was recorded. Conclusion: Infusion of lactic acid at the membrane lung inlet consistently increased VCO2ML providing a safe removal of carbon dioxide from only 250 ml/min extracorporeal blood flow in amounts equivalent to 50% production of an adult man.


2021 ◽  
Vol 49 (10) ◽  
pp. e1061-e1062
Author(s):  
Patrick M. Honore ◽  
Sebastien Redant ◽  
Thierry Preseau ◽  
Keitiane Kaefer ◽  
Leonel Barreto Gutierrez ◽  
...  

ASAIO Journal ◽  
2001 ◽  
Vol 47 (2) ◽  
pp. 114
Author(s):  
Jason B. Jayroe ◽  
Dongfang Wang ◽  
Donald J. Deyo ◽  
Scott K. Alpard ◽  
Joseph B. Zwischenberger

Perfusion ◽  
2019 ◽  
Vol 34 (7) ◽  
pp. 538-543 ◽  
Author(s):  
Alice Montalti ◽  
Mirko Belliato ◽  
Sandro Gelsomino ◽  
Sandro Nalon ◽  
Francesco Matteucci ◽  
...  

Background: Extracorporeal membrane oxygenation constitutes a complex support modality, and accurate monitoring is required. An ideal monitoring system should promptly detect ECMO malfunctions and provide real-time information to optimize the patient–machine interactions. We tested a new volumetric capnometer which enables continuous monitoring of membrane lung carbon dioxide removal (V′CO2ML), to help in estimating the oxygenator performance, in terms of CO2 removal and oxygenator dead space (VDsML). Methods: This study was conducted on nine pigs undergoing veno-arterial ECMO due to cardiogenic shock after induced acute myocardial infarction. The accuracy and reliability of the prototype of the volumetric capnometer (CO2RESET™, by Eurosets srl, Medolla, Italy) device was evaluated for V′CO2ML and VDsML measurements by comparing the obtained measurements from the new device to a control capnometer with the sweep gas values. Measurements were taken at five different levels of gas flow/blood flow ratio (0.5-1.5). Agreement between the corresponding measurements was taken with the two methods. We expected that 95% of differences were between d − 1.96s and d + 1.96s. Results: In all, 120 coupled measurements from each device were obtained for the V′CO2ML calculation and 40 for the VDsML. The new capnometer mean percentage bias (95% confidence interval limits of agreement) was 3.86% (12.07-4.35%) for V′CO2ML and 2.62% (8.96-14.20%) for VDsML. A negative proportional bias for V′CO2ML estimation with the new device was observed with a mean of 3.86% (12.07-4.35%). No correlations were found between differences in the coupled V′CO2ML and VDsML measurements and the gas flow/blood flow ratio or temperature. Coupled measurements for V′CO2ML showed strong correlation (rs = 0.991; p = 0.0005), as did VDsML calculations (rs = 0.973; p = 0.0005). Conclusion: The volumetric capnometer is reliable for continuous monitoring of CO2 removal by membrane lung and VDsML calculations. Further studies are necessary to confirm these data.


ASAIO Journal ◽  
1996 ◽  
Vol 42 (2) ◽  
pp. 71 ◽  
Author(s):  
R. L. Brunston ◽  
W. Tao ◽  
V. J. Cardenas ◽  
A. Bidani ◽  
D. L. Traber ◽  
...  

2014 ◽  
Vol 3 ◽  
Author(s):  
Yerbol Mussin ◽  
Richard Jeffries ◽  
Denis Bulanin ◽  
Zhaksybay Zhumadilov ◽  
Farkhad Olzhayev ◽  
...  

Introduction. Adult extracorporeal carbon dioxide removal (ECCO2R) systems and pediatric ECMO share the common objectives of having a low blood flow rate and low priming volume while safely maintaining sufficient respiratory support. The Hemolung is a highly simplified adult ECCO2R system intended for partial respiratory support in adult patients with acute hypercapnic respiratory failure. The objective of this work was to conduct pre-clinical feasibility studies to determine if a highly efficient, active-mixing, adult ECCO2R system can safely be translated to the pediatric population. Methods. 14 healthy nonsedated juvenile sheep were used for acute (2 animals) and 7-day chronic (12 animals) in-vivo studies to evaluate treatment safety independently of respiratory related injuries. In all evaluations, we hypothesized that gas exchange capabilities of the Hemolung RAS in this model would be equivalent to the adult configuration performance at similar blood flows - minimum CO2 removal of 50 mL/min at a venous partial pressure of CO2 equal to 45 mmHg. Target blood flow rates were set to a minimum of 280 mL/min. Swan Ganz catheters were used under general anesthesia in the two acute subjects to evaluate blood gas status in the pulmonary artery.Results. The Hemolung RAS was found to have adequate gas exchange and pumping capabilities for full respiratory support for subjects weighing 3 – 25 kg. The Hemolung device was estimated to provide a partial respiratory support for subjects weighing 27 – 34 kg. The seven-day studies in juvenile sheep demonstrated that veno-venous extracorporeal support could be provided safely at low flows with no significant adverse reactions related to device operation.Conclusion. The study outcomes suggest the potential use of the Hemolung RAS in a veno-venous pediatric configuration to safely provide respiratory support utilizing a significantly less complex system than traditional pediatric ECMO. 


Sign in / Sign up

Export Citation Format

Share Document